| Document Date: 2014-06-19 10:48:24
Open Document File Size: 309,49 KBShare Result on Facebook
City Bethesda / / Company NCI Frederick National Laboratory / Chemotherapy Resistance / / Country United States / / Event FDA Phase / / Facility NCI Frederick National Laboratory / National Cancer Institute / / IndustryTerm magnetic resonance imaging / / MedicalCondition SCLC Small Cell Lung Cancer / cancers / advanced stage disease / Tumor / limited-stage disease / primary disease / cancer / disease / recalcitrant cancer / biological Small Cell Lung Cancer / Small cell lung cancer / unusually chemosensitive and radiosensitive disease / bone metastases / experience disease / Abbreviations Small Cell Lung Cancer / SCLC / Response Evaluation Criteria In Solid Tumors / Lung Cancer / Extensive-stage disease / etoposide Small Cell Lung Cancer / squamous cell cancer / metastases / distant metastases / adenocarcinoma / / MedicalTreatment radiation therapy / chemotherapy / surgery / immunotherapy / radiation / / Organization National Cancer Institute / NCI's Clinical Trials and Translational Research Advisory Committee / FDA / Advisory Committee / / Person Charles Rudin / John Minna / / Position driver / / Product carboplatin / cisplatin / etoposide / SCLC / Japan29 / / ProvinceOrState Maryland / / Technology Radiation / magnetic resonance imaging / tomography / siRNA / gene expression / Cell Signaling / stem cells / /
SocialTag |
Small Cell Lung Cancer Seizing on Opportunities to Translate Recent Research into the Clinic for New Diagnostics and Interventions The Small Cell Lung Cancer Working Group Clinical Trials and Translational Research Advis